May 22, 2025

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unveiling an 88% Potential Upside in Biotech

Investors seeking high-growth opportunities in the biotechnology sector may find themselves captivated by Benitec Biopharma Inc. (NASDAQ: BNTC). With an impressive potential upside of 88.18%, the..

Sprout Social, Inc (SPT) Stock Analysis: Unveiling a 34% Upside Potential

Sprout Social, Inc (SPT), a prominent player in the technology sector, operates in the dynamic software application industry. Headquartered in Chicago, Illinois, Sprout Social is known..

Health Catalyst, Inc (HCAT) Stock Analysis: 116% Potential Upside in the Health Information Services Sector

Health Catalyst, Inc (NASDAQ: HCAT), a prominent player in the health information services industry, presents a compelling opportunity for investors seeking exposure to the healthcare sector...

Sanara MedTech Inc. (SMTI) Investor Outlook: Unpacking a 57.96% Potential Upside

Sanara MedTech Inc. (NASDAQ: SMTI), a prominent player in the healthcare sector, specializes in developing and distributing advanced medical instruments and supplies. Based in Fort Worth,..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Uncovering a 296% Upside Potential

Candel Therapeutics, Inc. (NASDAQ: CADL), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment and..

Terns Pharmaceuticals (TERN) Stock Analysis: A Potential 539% Upside in the Biotech Arena

Terns Pharmaceuticals, Inc. (TERN), a clinical-stage biopharmaceutical company, continues to capture the attention of investors with its robust pipeline targeting oncology and obesity. Headquartered in Foster..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 21.12% Potential Upside in Health Information Services

TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare sector, is garnering significant attention from investors with its potential 21.12% upside. Specializing in health information..

Immutep Limited (IMMP) Stock Analysis: Exploring a 389% Potential Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Immutep Limited (NASDAQ: IMMP) presents a compelling opportunity. Based in Sydney, Australia, this late-stage biotechnology company specializes..

Tvardi Therapeutics, Inc. (TVRD): Analyst Consensus Highlights 55% Potential Upside for Investors

Tvardi Therapeutics, Inc. (TVRD), a burgeoning player in the biotechnology sector, is generating significant buzz among investors with its innovative approach to tackling cancer, chronic inflammation,..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a 124% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare innovator based in Israel, operates in the medical devices industry with a focus on revolutionizing tomographic imaging. Despite its..

Varex Imaging Corporation (VREX) Stock Analysis: Unveiling a 117% Potential Upside with Strong Buy Ratings

Varex Imaging Corporation (NASDAQ: VREX) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Salt Lake..

Phathom Pharmaceuticals, Inc. (PHAT) Investor Outlook: Analyzing the 351.92% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, is currently making waves with its promising pipeline of gastrointestinal treatments. Headquartered in Florham..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 300% Potential Upside in the Medical Device Sector

For investors eyeing opportunities in the healthcare sector, particularly in medical devices, Senseonics Holdings, Inc. (SENS) presents an intriguing proposition. This commercial-stage medical technology company, headquartered..

Alumis Inc. (ALMS) Stock Analysis: Exploring a 344.56% Potential Upside in the Biotech Sector

Alumis Inc. (NASDAQ: ALMS), a notable player in the biotechnology industry, is capturing investor attention with its substantial potential upside of 344.56%. As a clinical-stage biopharmaceutical..

Cidara Therapeutics (CDTX) Stock Analysis: A Biotech Contender with a 55% Upside Potential

Cidara Therapeutics, Inc. (NASDAQ: CDTX) has positioned itself as a promising player in the biotechnology sector, with a focus on developing targeted therapies for life-threatening conditions,..

Aurora Cannabis Inc. (ACB) Stock Analysis: Examining Growth Amid Market Challenges

Aurora Cannabis Inc. (NYSE: ACB) continues to be a focal point in the cannabis industry, offering a mix of potential and risk that captures the attention..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating the Healthcare Sector with a Potential 106.61% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, is making waves with its advanced sequencing solutions designed to tackle genetically..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring a 393% Potential Upside in the Biotech Sector

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is currently capturing the attention of investors with its significant potential upside of 393.30%. Trading at $5.01 per share, the company..

UroGen Pharma Ltd. (URGN) Stock Analysis: A High-Stakes Bet with a Potential 643% Upside

UroGen Pharma Ltd. (NASDAQ: URGN) is catching the attention of investors with its striking potential for a 643.41% upside, according to the latest analyst ratings. Operating..

Outset Medical, Inc. (OM): Investor Outlook Reveals 29% Upside Potential Amidst Analyst Confidence

Outset Medical, Inc. (NASDAQ: OM), a pioneering player in the healthcare sector with a focus on medical devices, has been generating buzz among investors due to..

Search

Funds

May 22, 2025

Search

Funds

May 22, 2025

FTSE 100

Funds